Two of these patients, one with HER-2 positive breast cancer and other with EGFR wild-type lung adenocarcinoma, experienced neurological worsening and needed salvage therapy using repeat BV, resulting in immediate and durable symptomatic relief and radiological stabilisation for more than 20 months (Fig. 2a). This evidence concerns the gene EGFR and breast carcinoma.